Analysis of Selection Methods to Develop Novel Phage Therapy Cocktails Against Antimicrobial Resistant Clinical

Melissa E K Haines1, Francesca E Hodges1, Janet Y Nale1

  • 1Department of Genetics and Genome Biology, University of Leicester, Leicester, United Kingdom.

Insights

Bacteriophages offer a promising solution to combat antimicrobial resistance (AMR) in urinary tract infections. This study developed a novel phage cocktail effective against ESBL-producing E. coli and Klebsiella, identifying planktonic killing assays as a robust screening method.

Area of Science:

  • Microbiology and Virology
  • Antimicrobial Resistance (AMR) Research
  • Bacteriophage Therapy Development

Background:

  • Antimicrobial resistance (AMR) is a critical global health threat, particularly from Extended Spectrum Beta-Lactamase (ESBL)-producing Enterobacteriaceae like E. coli and Klebsiella.
  • These ESBL-producing bacteria are major causes of urinary tract infection (UTI)-associated sepsis and are listed as priority pathogens by the WHO.
  • Bacteriophages (phages), viruses that infect bacteria, represent a potential alternative strategy to combat AMR.

Purpose of the Study:

  • To develop a novel phage cocktail targeting ESBL-producing E. coli and Klebsiella strains commonly found in UK hospital urinary tract infections.
  • To compare different phage efficacy assays to identify the most robust and efficient methods for phage cocktail development.
  • To establish an efficient screening cascade for creating phage cocktails against other AMR bacterial species.

Main Methods:

  • A panel of 38 ESBL-producing clinical strains of E. coli and Klebsiella from urine samples was curated.
  • Sixty-eight phages were initially screened, with six selected for further testing against the 38 strains.
  • Four methods were used to assess phage efficacy: Direct Spot Test (DST), Efficiency of Plating (EOP), Planktonic Killing Assay (PKA), and biofilm assay.

Main Results:

  • The final six-phage cocktail demonstrated significant efficacy, killing 61% of the target strains (23/38) based on PKA data.
  • The cocktail was effective against 68% (13/19) of Klebsiella and 53% (10/19) of E. coli strains.
  • Planktonic Killing Assays (PKAs) were found to be as effective as Efficiency of Plating (EOPs) but less time-consuming, correlating well with EOP data.

Conclusions:

  • A six-phage cocktail was successfully developed, showing substantial killing activity against a panel of ESBL-producing E. coli and Klebsiella.
  • Planktonic Killing Assays (PKAs) are a reliable and efficient proxy for assessing phage virulence and informing phage cocktail design.
  • The study proposes an efficient screening cascade for developing phage cocktails against other priority AMR bacterial pathogens.